The Relationship Between Hormone Sensitivity and Imaging of Idiopathic Interstitial Pneumonia by Artificial Intelligence
IIP
1 other identifier
observational
150
1 country
1
Brief Summary
Application of artificial intelligence deep learning algorithm to analyze the relationship between hormone sensitivity of idiopathic interstitial pneumonia and imaging features of high resolution CT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedFirst Submitted
Initial submission to the registry
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedFirst Posted
Study publicly available on registry
December 7, 2021
CompletedDecember 7, 2021
June 1, 2021
1.4 years
June 30, 2021
November 23, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
clinical data and imaging feature ratios in both groups
clinical data including ages,gender,symptoms,signs,smoking history,complications,laboratory examination,lung function. Imaging feature including ground-glass opacity, reticulation, honeycomb and consolidation.
3-6 months after medication
Secondary Outcomes (1)
the relationship between imaging feature ratios and hormone sensibility
3-6 months after medication
Other Outcomes (1)
development of artificial intelligence algorithm model
3-6 months after medication
Study Arms (2)
Hormone sensitive group
Prednisone, 0.5mg/kgqd, 3-6months
Hormone insensitivity group
Prednisone, 0.5mg/kgqd, 3-6months
Interventions
Ground glass,honeycomb,reticulation, consolidation
Eligibility Criteria
From June 1, 2012 to December 31, 2020, all inpatients with IIP were admitted to the respiratory and critical care department of the Third Hospital of Peking University. Total patients are 150, 45 patients using hormone, average age 62 years old, 21 male.
You may qualify if:
- Clinical-pathological-radiology diagnosis of idiopathic interstitial pneumonia Hormone therapy was used; The follow-up data were complete, and the effect of hormone use could be judged.
You may not qualify if:
- Lung infection disease; Heart failure; Connective tissue disease; IIP Without hormone therapy ; IIP but the follow-up data were incomplete, and the effect of hormone use could not be judged.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bei He
Peking University Third Hospital Respiratory and critical care department
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 30, 2021
First Posted
December 7, 2021
Study Start
December 30, 2019
Primary Completion
June 1, 2021
Study Completion
June 30, 2021
Last Updated
December 7, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share